Day: January 5, 2026

Norwood Financial Corp Completes Acquisition of PB Bankshares, Inc.

Written by Customer Service on January 5, 2026. Posted in Mergers And Acquisitions.

HONESDALE, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) — Norwood Financial Corp (NASDAQ Global Market: NWFL) (“Norwood”), the holding company for Wayne Bank, announced today that it had completed its acquisition of PB Bankshares, Inc. (“PB Bankshares”) and its wholly-owned subsidiary, Presence Bank effective as of January 5, 2026. Presence Bank has been merged into Wayne Bank. At their election, PB Bankshares shareholders are receiving either $19.75 in cash or 0.7850 shares of Norwood common stock for each share of PB Bankshares common stock held subject to the allocation and proration procedures set forth in the Merger Agreement. In lieu of fractional shares of Norwood common stock, PB Bankshares shareholders will receive cash at the rate of approximately $29.08 per share of Norwood common stock. PB Bankshares’ shareholders who have not...

Acorn Substantially Expands Infrastructure Asset Management Technology Offerings for Cell Towers, Data Centers and Utilities

Written by Customer Service on January 5, 2026. Posted in Public Companies.

WILMINGTON, Del., Jan. 05, 2026 (GLOBE NEWSWIRE) — Acorn Energy, Inc. (Nasdaq: ACFN), a provider of remote monitoring and control solutions for critical infrastructure assets, today announced a strategic partnership with Israel-based AIO Systems, Ltd. to market, distribute, integrate and sell AIO’s best-in-class solutions for cell tower, data center and utility infrastructure asset management to customers in North America. The addition of AIO’s solutions, which have been deployed in over 110,000 sites, across 15 countries outside the U.S., substantially expands Acorn’s offerings and total addressable market. Acorn has secured exclusive rights to market, integrate and sell AIO’s products and solutions under its OmniMetrix brand in the United States, Mexico and Canada. Acorn will invest in personnel and resources, as well as services...

Genmab to Present at the 44th Annual J.P. Morgan Healthcare Conference

Written by Customer Service on January 5, 2026. Posted in Public Companies.

Media Release COPENHAGEN, Denmark; January 5, 2026 Genmab A/S (Nasdaq: GMAB) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco at 3:45 PM PST / 6:45 PM EST on January 13, 2026, 12:45 AM CET on January 14, 2026. The live and archived webcast of the presentation will be available on Genmab’s website at https://ir.genmab.com/events-presentations. About Genmab Genmab is an international biotechnology company dedicated to improving the lives of people with cancer and other serious diseases through innovative antibody medicines. For over 25 years, its passionate, innovative and collaborative team has advanced a broad range of antibody-based therapeutic formats, including bispecific antibodies, antibody–drug conjugates (ADCs), immune-modulating...

Vaisala Xweather Annual Lightning Report 2025: U.S. lightning hits eight-year high

Written by Customer Service on January 5, 2026. Posted in Public Companies.

Total lightning density US County 2025Total lightning density in the US by County 2025Lightning density: Global 2025Lightning density: Global 2025Ryan SaidRyan Said, Senior Scientist at Vaisala XweatherRyan SaidRyan Said, Senior Scientist at Vaisala XweatherVaisala XweatherPress releaseJanuary 5, 2026 Vaisala Xweather Annual Lightning Report 2025: U.S. lightning hits eight-year high 252 million lightning strikes recorded in 2025 with the peak lightning day arriving weeks ahead of storm season. Vaisala Xweather’s Annual Lightning Report reveals lightning activity in the U.S. surged to an eight-year high in 2025, with 252 million lightning strikes, a 20% increase from 2024. Capturing more than 99% of thunderstorms worldwide, the network detected over 2 billion global lighting events, and 7% decrease over...

Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice

Written by Customer Service on January 5, 2026. Posted in Mergers And Acquisitions.

Acquisition adds complementary asset to the Pelthos commercial portfolio Xeglyze is a novel, FDA-approved prescription medication indicated for the topical treatment of head lice infestation in patients 6 months of age and olderDURHAM, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced it has acquired Xeglyze® (abametapir) from Hatchtech Pty Ltd., an Australian biotech company, for $1.8 million. Xeglyze is a pediculicide indicated for the topical treatment of head lice infestation in patients 6 months of age and older. The prescription medication was approved by the U.S. Food and Drug Administration (“FDA”) in July 2020. The acquisition will provide...

Form 8.3 – [IDOX PLC – 02 01 2026] – (CGWL)

Written by Customer Service on January 5, 2026. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree IDOX PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Form 8.3 – [IQE PLC – 02 01 2026] – (CGAML)

Written by Customer Service on January 5, 2026. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree IQE PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference

Written by Customer Service on January 5, 2026. Posted in Public Companies.

NEW YORK and WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company’s participation in the 44th Annual J.P. Morgan Healthcare conference in San Francisco. Marino Garcia, CEO of Dianthus Therapeutics, will present a corporate overview on Monday, January 12, 2026 at 3:00 pm PST / 6:00 p.m. EST and will host one-on-one meetings with investors. A webcast of this presentation may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website. About Dianthus TherapeuticsDianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to...

Copper Quest Acquires 100% Interest in the Kitimat Copper-Gold Project

Written by Customer Service on January 5, 2026. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, Jan. 05, 2026 (GLOBE NEWSWIRE) — Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that further to its news release dated October 30th, 2025, it has exercised its option under an agreement with Bernie Kreft dated October 29, 2025, and has acquired an undivided 100% right, title, and interest in the Kitimat Copper-Gold Project (the “Project”), located approximately 10 kilometers northwest of the deep-water port community of Kitimat, British Columbia. PROJECT OVERVIEW The Kitimat Copper-Gold Project covers approximately 2,954 hectares within the Skeena Mining Division of northwestern British Columbia. The Project is year-round road-accessible via a network of logging and mineral exploration roads extending north from Kitimat. The...

Allot to Present at the Needham Growth Conference on January 14, 2026

Written by Customer Service on January 5, 2026. Posted in Public Companies.

Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative Security-as-a-Service (SECaaS) and network intelligence solutions for communications service providers and enterprises, today announced that its management will be presenting and meeting with investors at the Needham Growth Conference taking place in New York City on Wednesday, January 14, 2026. Allot’s CEO, Eyal Harari will be presenting live on Wednesday, January 14, 2026 at 11:00a.m. ET. The presentation will also be webcast at that time. To watch the webcast, please visit either a link on Allot’s investor relations website or directly from the following link: https://wsw.com/webcast/needham148/allt/2253699 Management will also be available for one-on-one with institutional investors at Needham that day. For more information about the conference, or to...

Day: January 5, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals